Login

Tina Ardon, M.D. Family Physician, Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Dr. Tina Ardon, is a Mayo Clinic family medicine physician in Jacksonville, Florida.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Adventure Box CEO Christopher Kingdon Discusses Q2 Performance and Strategic Plans | Christopher Kingdon, CEO, Adventure Box Technology AB.
00:10:00
investment vehicle to empower historically overlooked people and market|Alison Rapaport Stillman,Partner,Serena Ventures
00:10:00
invest and support founders from seed until the later stages|Adam Berger,Managing Director,Insight Partners
00:10:00
Oil and Gas Explorer and Developer in Northeast BC Oil and gas exploration developer in Northeast BC, Canada | Coelacanth Energy (TSXV: CEI | Robert J Zakresky, CEO, Coelacanth Energy IncCEI:CVE
00:10:00
Blackstone we deliver for investors by building businesses that power tomorrow’s economy|Stephen A. Schwarzman,Chairman,The Blackstone Group
00:10:00
Canadian North Resources Reports Exciting Drilling Results and Expanding Resource Potential
00:10:00
Roth vs. Pretax Retirement Accounts: Which Offers the Better Deal? | MIKE WREN - CEO, Managing Principal & Financial Advisor of Legacy Financial Strategies, LLC
00:10:00
prefer to invest alongside a lead VC check|Amit Avner,General Partner,Operator Partners
00:10:00
Angi CEO Oisin Hanrahan on Quarterly Earnings and Market Trends | Oisin Hanrahan, CEO, Angi Inc.
00:10:00
Building Impactful Companies|Scott Sandell,Partner,New Enterprise Associates (NEA)
00:10:00
The Upside of Getting Dumped: A Look at the Research Affiliates Deletions Index (NIXT) and ETF | Rob Arnott - Forrest Henslee
00:10:00
Commerzbank's Transformation Under Manfred Knof: Strategies and Future Outlook | Manfred Knof , CEO ,  Commerzbank.

© 2026 Nehu